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Boffetta P, Matisane L, Mundt KA, Dell LD. Meta-analysis of studies of occupational exposure to vinyl chloride in
relation to cancer mortality. Scand J Work Environ Health 2003;29(3):220–229.
Objective   A meta-analysis was made of studies addressing occupational exposure to vinyl chloride in relation
to cancer mortality.
Methods   Two recently updated multicenter cohort studies and six smaller studies were identified. For selected
neoplasms, standardized mortality ratios (SMR) and 95% confidence intervals (95% CI) were abstracted (or
calculated from raw data). In cases of lack of heterogeneity (P-value ≥0.01), meta-analyses were conducted
using a random-effects model.
Results   With SMR values ranging from 1.63 to 57.1, all six studies for which these ratios could be obtained
suggested an increased risk of liver cancer. For four of these studies, excesses persisted when known cases of
angiosarcoma of the liver (ASL) were excluded. The meta-SMR for liver cancers other than ASL (based on the
2 large cohorts) was 1.35 (95% CI 1.04–1.77). The meta-SMR for lung cancer was 0.90 (95% CI 0.77–1.00,
based on 5 studies), although higher SMR values were reported in early studies. The meta-SMR for brain cancer,
based on 5 studies, was 1.26 (95% CI 0.98–1.62). For soft tissue sarcomas, the meta-SMR based on 4 studies was
2.52 (95% CI 1.56–4.07). The meta-SMR for lymphatic and hematopoietic neoplasms in the 2 large studies was
0.90 (95% CI 0.75–1.01), although 3 of the smaller studies reported significant excesses.
Conclusions   Apart from the known risk of ASL, workers exposed to vinyl chloride may experience an
increased risk of hepatocellular carcinoma and soft-tissue sarcoma; however, these results may have been
influenced by the underdiagnosis of true ASL. Increased mortality from lung and brain cancers and from
lymphatic and hematopoietic neoplasms cannot be excluded; mortality from other neoplasms does not appear to
be increased.
Key terms   angiosarcoma of the liver, brain cancer, hematopoietic neoplasms, liver cancer, lung cancer,
occupational exposure.
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Vinyl chloride is a monomer used to produce polyvinyl
chloride, a widely used plastic. It has been classified
by the International Agency for Research on Cancer
(IARC) as a group 1 carcinogen, with sufficient evi-
dence of carcinogenicity in humans (1). To date, the
only cancer that has clearly been associated with vinyl
chloride exposure is angiosarcoma of the liver. In addi-
tion, neoplasms of the liver other than angiosarcoma,
malignancies of the lung, brain and skin, and neoplasms
of the lymphatic and hematopoietic system have been
reported in excess in studies of vinyl chloride exposure
(1–3).
Two large, multicenter epidemiologic studies of
workers exposed to vinyl chloride have been reported
recently (4–5). Their results are also available as de-
tailed reports (6–7). These studies combine populations
of exposed workers included in previous investigations
and extend the follow-up. Six additional, smaller stud-
ies of populations not included in either of the two multi-
center studies have been reported. Given the multiplicity
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of reports on several populations exposed to vinyl chlo-
ride and the heterogeneity of the results, we considered
it useful to review the available evidence systematical-
ly, to combine formally the study results, and to discuss
the reasons for the heterogeneity of the results. Using
the results of these eight studies, we therefore present
meta-analyses of cancer mortality risk among cohorts
exposed to vinyl chloride, with the aims of formally as-
sessing the heterogeneity of the results among availa-
ble studies and of providing precise risk estimates by
pooling study-specific results.
We focused on cohorts with exposure to vinyl chlo-
ride in monomer production and in polymerization, as
these processes are presumed to represent the predomi-
nant exposure of vinyl chloride workers. However, work-
ers may have also been exposed to ethylene dichloride,
polyvinyl chloride dust, fillers, colorants, plasticizers
and other additives, asbestos, and other potentially haz-
ardous agents. Unfortunately, the published studies had
not been able to measure exposure to vinyl chloride mon-
omer or any other occupational exposure directly. Further-
more, exposures to other cancer risk factors, such as to-
bacco smoking, had not been measured in the source
studies, and some level of confounding may have re-
sulted for cancers related to these factors, especially if
they were associated with employment in this industry.
Subjects and methods
Using Medline, we searched the peer-reviewed medi-
cal literature, through June 2002, for data on cancer
mortality or morbidity associated with exposure to vi-
nyl chloride. We identified eight independent studies
(table 1).
Two of the studies selected for the meta-analysis (4,
5) were multicenter investigations including, or over-
lapping with, populations studied by other authors. The
European multicenter study (5, 14) included most of the
persons previously studied in the United Kingdom (15,
16), Norway (17, 18), Italy (19, 20), and Sweden (21–
23), but the populations described in national reports did
not completely overlap with those in the large multicent-
er study, due to different entry criteria (table 2). There-
fore, the results of the individual studies could not be
included in a meta-analysis. Their overlap with the mul-
ticenter study was so substantial that the observations
could not be considered independent, and only results
from the multicenter studies were used in the meta-anal-
yses.
In the United States, the cohort initially studied by
Tabershaw & Gaffey (24), in which the association be-
tween vinyl chloride and angiosarcoma of the liver was
first demonstrated, was subsequently expanded to
Table 1. Independent studies of cancer among vinyl chloride workers.
Study Countries Plants (N) Workers (N) Entry criteria Follow-up Person-years
Ward et al, 2001 (5) Italy, Sweden, 19 12 700 One-year employment in exposed jobs, 1955–1997 324 706
Norway, United Kingdom 1955–1986
Mundt et al, 2000 (4) United States, Canada 37 10 109 One-year employment in exposed jobs, 1942–1995 316 520
1942–1972
Smulevich et al, 1988 (8) Former Soviet Union 1 3 232 One-month employment, 1939–1977 1939–1977 43 216
Laplanche et al, 1992 (9) France 12 1 100 Present in 1981       ?–1988 8 299
Theriault & Allard, 1981 (10) Canada 1 451 Employment in 1948–1972 1948–1977 10 192
Weber et al, 1981 (11) Germany n/a 7 021 Not specified       ?–1974 73 734
Huang, 1996 (12) China 14 5 958 Employment in 1958–1981 1958–1981 67 358
Wong et al, 2002 (13) Taiwan 6 3 239 Employment in 1950–1992 1985–1997 40 557
Table 2. Study populations included in the European multicenter cohort (5).
Study Countries Workers (N) Years of employment  Years of follow-up
Simonato et al, 1991 (14) Italy, Sweden, Norway, United Kingdom 12 706 1945–1986 1955–1986
Langard et al, 2000 (18) Norway 428 1950–1969 1953–1993
Heldaas et al, 1984 (17) Norway 454 1950–1969 1953–1979
Pirastu et al, 1998 (20) Italy 1 259 1953–1985 1953–1997
Belli et al, 1987 (19) Italy 1 256       ?–1984 1953–1984
Hagmar et al, 1990 (23) Sweden 2 031 1945–1980 1961–1985
Molina et al, 1981 (22) Sweden 1 970 1945–1974 1961–1976
Byren et al, 1976 (21) Sweden 771       ?–1974       ?–1974
Jones et al, 1988 (16) United Kingdom 5 560 1940–1974       ?–1984
Fox & Collier, 1977 (15) United Kingdom 7 561 1940–1974 1940–1974
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Table 3. Study populations included in the American multicenter cohort study (4).
Study Plants (N) Overlap Workers (N) Years of employment Years of follow-up
Wong et al, 1991 (26) 37 Complete 10 173 1942–1972 1942–1982
Cooper, 1981 (25) 37 Complete 10 173 1942–1972 1942–1972
Tabershaw & Gaffey, 1974 (24) 33 Complete 8 384 1942–1972 1942–1972
Dahar et al, 1988 (27) 1 Partial 594 1942–1960 1942–1982
Ott et al, 1975 (28) 1 Partial 594 1942–1960 1942–1973
Buffler et al, 1979 (29) 1 Partial 464 1948–1975 1948–1975
Wu et al, 1989 (30) 1 Partial 3 635 1942–1973 1942–1986
Waxweiler et al, 1976 (31) 4 Complete 1 294 1942–1973 1942–1973
Nicholson et al, 1975 (32) 1 Complete 257 1946–1973 1956–1974
Monson et al, 1974 (33) 2 Complete 161a         ·· 1947–1973
a Deceased workers.
include additional populations and formed the North
American multicenter cohort (25), which was later up-
dated through 1982 (26). Several publications have been
based on completely or partially overlapping popula-
tions (table 3). Most recently, this cohort was updated,
including the identification and elimination of duplicate
employees and the restoration of a substantial number
of cohort members previously lost to follow-up (4).
Only results from this last multicenter study are includ-
ed in the meta-analysis.
The study from Taiwan (13) was an update and ex-
pansion of a previous study comparing morbidity due
to liver conditions among vinyl chloride workers with
that of a group of workers manufacturing optical equip-
ment and motorcycles (34).
For each of the remaining studies, we abstracted
numbers of observed and expected deaths for all ma-
lignant neoplasms and, except for the study by La-
planche et al (9), for specific neoplasms, standardized
mortality ratios (SMR), and 95% confidence intervals
(95% CI). For a few categories of cause of death that
were not reported but for which data were available, we
calculated the SMR or 95% CI values from the raw data.
Before pooling any results, we assessed the heteroge-
neity of the study-specific results with a statistical test
(35). When the P-value of the test for heterogeneity was
≥ 0.01, we concluded that the study-specific results were
adequately similar (ie, lack of evidence that the results
were dissimilar or heterogeneous), we conducted a
meta-analysis based on random-effects modeling, and
we calculated meta-SMR values and their 95% CI.
As it was known that vinyl chloride exposure is a
cause of liver angiosarcoma, we aimed at disentangling
the mortality related to this neoplasm from that related
to other types of liver cancer (mainly hepatocellular car-
cinoma). However, only for the European multicenter
study were detailed results by histology reported. We
therefore excluded the deaths reported to be from angi-
osarcoma from the total number of deaths from prima-
ry liver cancers, without modifying the number of ex-
pected deaths. This approach was justified because, out
of all primary liver cancers, less than 1% are angiosar-
comas, in both European (36) and American (37) pop-
ulations. A meta-analysis for angiosarcoma of the liver
was not conducted as relevant SMR values were diffi-
cult to estimate due to the extreme rarity of the disease
in the general population.
In several studies, results were presented for indi-
rect indicators of exposure to vinyl chloride, such as the
duration of employment and latency. We did not attempt
to perform a meta-analysis according to such indicators
because of the heterogeneity among them. However, we
used the study-specific evidence in the discussion of our
results. Only in the European multicenter study, a quan-
titative estimate of vinyl chloride exposure was availa-
ble, which was based on job-, plant- and calendar-peri-
od-specific exposure matrices (38).
Results
We report the results of the individual studies in table
4 and the results of the meta-analyses in table 5. The
meta-analyses were based (depending on the availabil-
ity of data and the heterogeneity of results for specific
outcomes of interest) on a maximum of 43 810 workers
included in eight studies, among whom 2079 cancer
deaths occurred. This total of all cancer deaths is very
close to what would be expected in a comparable unex-
posed population (SMR 1.01, 95% CI 0.95–1.08). The
two multicenter studies contributed 86% of these can-
cer deaths and therefore tended to drive the results of
the meta-analyses.
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Table 4. Mortality by cause. (N = number of observed deaths, SMR = standardized mortality ratio, 95% CI = 95% confidence interval, CNS =
central nervous system, NHL = non-Hodgkin’s lymphoma)
Cause of death a Ward et al, 2001 (5) Mundt et al, Laplanche et al, Smulevich et al, Theriault & Allard Weber et al, Huang, 1996 (12) Wong et al,
2000 (4) 1992 (9) b 1988 (8) 1981 (10) 1981 (11) 2002 (13)
N SMR 95% CI N SMR 95% CI N SMR 95% CI N SMR 95% CI N SMR 95% CI N SMR 95% CI N SMR 95% CI N SMR  95% CI
All malignancies
(140–208) 883 0.99 0.93–1.06 895 0.96 0.90–1.02 38 1.3 0.8–2.1 63 1.07 0.82–1.36c 20 1.22 0.75–1.89c 94 1.12 0.91–1.37c 29c 0.85c 0.57–1.23c 57 1.30 0.99–1.69
Liver cancer
(155) 53 2.40 1.80–3.14 80d 3.59 2.84–4.46 6 ·· ·· – · · 8 57.1 24.6–113c 12 15.2 7.86–26.6c 10e 1.36 0.65–2.51c 25 1.78 1.15–2.62
   Liver, except
   angiosarcoma
   of the liver f 28 1.27 0.84–1.83 40c,d 1.8c 1.3–2.5c 3 ·· ·· – · · – · · 8 10.1 4.37–20.0c ·· ·· ·· 25 1.78 1.15–2.62
Lung cancer
(162) 272 0.95 0.84–1.07 303 0.82 0.73–0.92 8 ·· ·· 17 1.39 0.81–2.23c 2g 0.34 0.04–1.25c ·· ·· ·· 5 ·· ·· 4h 0.59 0.16–1.52
Soft-tissue
sarcoma (171) 6 1.89 0.69–4.11 12 2.70 1.39–4.72 1 ·· ·· 1h 1.43 0.02–7.95c 2 i 5.26 0.59–19.0c ·· ·· ·· ·· ·· ·· ·· ·· ··
Skin cancer and
melanoma (172–173) 20 1.69 1.03–2.60 12 0.64 0.33–1.12 3 ·· ·· 1 2.00 0.03–11.1c – [see soft tissue] ·· ·· ·· ·· ·· ·· ·· ·· ··
Brain and CNS
cancer (191–192) 24 0.93 0.60–1.39 36 1.42 1.00–1.97 ·· ·· ·· 4 1.54 0.41–3.94c – ·· ·· 2 j 1.62 0.18–5.85c 1 ·· ·· 2 j 2.86c  0.57–9.16c
Neoplasms of lymphatic
and  hematopoietic
system (200–208) 62 0.94 0.72–1.21 71 0.86 0.67–1.08 1 ·· ·· 10 4.55 2.81–8.36c 1 0.60 0.01–3.33c 15 2.14 1.12–3.53c 1 ·· ·· 7 2.71 1.09–5.60
NHL
and multiple myeloma
(200, 202, 203) 33c 0.98c 0.67–1.37c 37c 0.86c 0.60–1.18c ·· ·· ·· 5k 4.17 1.34–9.72c – ·· ·· ·· ·· ·· – ·· ·· ·· ·· ··
Hodgkin’s [see NHL and
lymphoma (201) 7 1.03 0.41–2.12 3 0.44 0.09–1.29 ·· ·· ·· myeloma] – ·· ·· ·· ·· ·· – ·· ·· ·· ·· ··
Leukemia
(204–208) 22 0.87 0.54–1.31 31 0.94 0.64–1.34 ·· ·· ·· 5 5.00 1.61–11.7c – ·· ·· ·· ·· ·· 1 ·· ·· ·· ·· ··
a Codes of the International Classification of Diseases (9th revision) in parentheses.
b Cancer incidence comparison with workers from the same plant but unexposed to vinyl cloride.
c Derived from raw data.
d Liver and biliary tract (155–156).
e Men only – no cases among women.
f Expected numbers based on all liver cancers.
g Respiratory organs (160–163).
h Bone and soft tissue (170–171).
i Bone, soft tissue and skin (170–173).
j Brain (191).
k Lymphoma and multiple myeloma (200–203).
Table 5. Results of the meta-analysis.a (SMR = standardized mortality ratio, 95% CI = 95% confidence interval, NHL = non-Hodgkin’s
lymphoma)
Causes of death b All studies Two multicenter studies
P value for heterogeneity SMR 95% CI P value for heterogeneity SMR 95% CI
All malignancies (140–208) 8   0.2 1.01 0.95–1.08 0.5 0.97 0.93–1.02
Liver (155) 6 <0.001 · · 0.03 2.96 2.00–4.39
  Liver except angiosarcoma of the liver 4 <0.001 · · 0.7 1.35 1.04–1.77
Lung (162) 5   0.1 0.90 0.77–1.06 0.09 0.88 0.76–1.01
Bone (170) 2  c c c 0.9 1.15 0.52–2.53
Soft tissue (171) 4   0.7 2.52 1.56–4.07 0.5 2.41 1.45–3.99
Skin (172–173) 3   0.05 1.11 0.49–2.54 0.01 1.06 0.41–2.73
Brain (191–192) 5   0.4 1.26 0.98–1.62 0.12 1.17 0.77–1.77
Thyroid (193) 2  c c c 0.9 1.41 0.49–4.00
Neoplasms of the lymphatic and
hematopoietic systems (200–208) 6 <0.001 · · 0.6 0.90 0.75–1.07
NHL, myeloma (200, 202, 203) 3   0.01 1.23 0.70–2.19 0.6 0.91 0.71–1.17
Hodgkin’s lymphoma (201) 2  c c c 0.3 0.80 0.37–1.71
Leukemia (204–208) 3   0.005 · · 0.8 0.91 0.69–1.21
a The meta-analysis was performed when the P-value for heterogeneity was > 0.01.
b Codes of the International Classification of Diseases (9th revision) in parentheses.
c Only the results of two multicenter studies available; see the right side of the table.
Number of
studies
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Liver cancer
The SMR of liver cancer was increased in all the avail-
able studies except the one from the former Soviet Un-
ion, which reported no deaths from this neoplasm. For
the remaining studies, the SMR ranged from 1.36 to
57.1, and the results were too heterogeneous to be in-
cluded in a meta-analysis. Out of the total 133 deaths
that occurred from liver cancer in the two multicenter
studies, 65 were known to be cases of angiosarcoma.
The remaining 68 deaths included histologically con-
firmed hepatocellular carcinomas, liver cancers of oth-
er known histology, and primary liver cancers with an
unspecified histology (possibly including angiosarco-
mas). When documented angiosarcoma deaths were ex-
cluded, and the expected numbers were not modified,
the resulting pooled SMR was 1.35 (95% CI 1.04–1.77).
Total liver cancer mortality was reported according
to the duration of employment in three studies (figure
1). On one hand, in the two multicenter studies, the SMR
was close to unity for workers employed up to 7 years,
and a plateau was suggested (SMR between 6 and 7)
for a duration of employment of more than 25 years. In
the German study, on the other hand, the SMR increased
steeply even for workers with less than 7 years of em-
ployment. A decrease in the SMR of total liver cancer
mortality by year of first employment was found in both
multicenter studies, and the patterns were remarkably
similar (figure 2). Neither study was adequate for a prop-
er assessment of the SMR for workers first employed
after 1975 in that the North American study did not in-
clude people first employed after 1972 and the Europe-
an study had a small number of employees and an inad-
equate length of follow-up.
Lung cancer
The results on lung cancer were fairly heterogeneous.
Decreased mortality was reported in four of five stud-
ies, and was statistically significant in the North Amer-
ican study (table 4). A nonsignificant increase in the
SMR was reported in the study from the former Soviet
Union. The meta-SMR was 0.90 (95% CI 0.77–1.06).
In neither of the two multicenter studies was there a sug-
gestion of a trend with time since first exposure or du-
ration of exposure (data not shown in detail).
Soft-tissue sarcoma
There were 22 deaths from soft-tissue sarcoma reported
in the available studies. (In the studies from Canada and
the former Soviet Union, the SMR values for soft-tis-
sue sarcoma were reported in combination with other
nosological groups, whereas in the Canadian study the
two observed deaths were soft-tissue sarcomas.) The
meta-SMR was 2.52 (95% CI 1.56–4.07). Three of the
six deaths coded as soft-tissue tumors in the European
multicenter study were found to be cases of liver angi-
osarcoma whose primary site had been miscoded (5).
However, in the North American study, only 4 of the
12 soft-tissue cancers were angiosarcomas with site not
specified, and 7 others were specific soft-tissue cancers
other than angiosarcoma.
Skin cancer
The results on mortality from skin cancer, including both
melanoma and nonmelanoma cancer, were heterogene-
ous, but there was no indication of an increased risk
(pooled SMR 1.11, 95% CI 0.49–2.54). Among the two
large studies, the European one generated a statistically
significant positive SMR (which was largely due to an
excess incidence in Norway), whereas the North Amer-
ican study suggested a moderate deficit that was not sta-
tistically significant.
Brain cancer
A total of 66 deaths from brain cancer was reported in
four studies (meta-SMR 1.23, 95% CI 0.95–1.58). The
increase in the meta-SMR was mainly due to the North
American multicenter study, in which the excess of
mortality was most apparent between 1970 and 1979,
Figure 1. Standardized mortality ratio (SMR) of liver cancer by duration
of employment.
Figure 2. Standardized mortality ratio (SMR) of liver cancer by year of
first employment.
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but not in subsequent years (4). In neither of the two
large studies was a trend with duration of exposure sug-
gested (figure 3).
Cancer of the lymphatic and hematopoietic systems
The results from six studies reporting malignancies of
the lymphatic and hematopoietic systems were hetero-
geneous. When we restricted the analysis to the two
multicenter cohorts, however, the heterogeneity was re-
duced and the meta-SMR was 0.90 (95% CI 0.75–1.07).
However, the studies from the former Soviet Union (8),
Canada (10), and Taiwan (13) reported significantly in-
creased mortality. We were able to break these data into
three categories, comprising non-Hodgkin’s lymphomas
and multiple myeloma (ICD 200, 202, 203), Hodgkin’s
lymphoma (ICD 201), and leukemia (ICD 204–208).
There was no indication of an increased SMR for any
of these categories of neoplasms.
Discussion
Our study provided the most precise estimates of can-
cer risk among workers exposed to vinyl chloride. Fur-
thermore, it provided direct evidence of agreement for
most of the results of the two main studies. Among the
original results of our meta-analysis, beyond what has
been reported in the individual studies, is the evidence
of (i) an increased risk of liver cancer after the exclu-
sion of known deaths from angiosarcoma of the liver,
(ii) a lack of increase in brain and lung cancer risk, and
(iii) a possible increased risk of soft-tissue sarcoma.
None of the studies pointed out a significant increase
in total mortality from malignancies. The total number
of observed cancer deaths was essentially equal to that
expected; thus the increase in risk of any specific can-
cer, most notably angiosarcoma of the liver and possi-
bly liver cancer, was offset by deficits of deaths from
other types of cancer. In most studies, a substantial and
highly significant deficit of all nonmalignant causes of
death has been noted, and this outcome is compatible
with generally healthy working populations. This effect
of selection of healthy persons for work on mortality is
typically not seen for malignancies, especially with in-
creased follow-up (39).
As expected, there was a strong indication of an in-
crease in the SMR for primary liver cancer. As suffi-
cient evidence exists for a causal relationship between
occupational exposure to vinyl chloride and angiosar-
coma of the liver, we focused our interest on other liver
cancers by removing known angiosarcoma of the liver
deaths from the analyses. We found a weak but statisti-
cally significant increase in the SMR of liver cancers
other than angiosarcoma. However, it should be point-
ed out that the group of primary liver cancers other than
angiosarcoma includes deaths without a histologically
verified diagnosis. Some of these liver cancer deaths
may have been cases of angiosarcoma, especially among
deaths observed in early periods, when the diagnostic
capability and the awareness of the relationship with
vinyl chloride were poor. In this respect, it is worth not-
ing that the SMR of this category was lower in the Eu-
ropean multicenter study than in the North American
one. In the former study, the authors performed a more-
detailed review of cases of liver cancer than in the North
American study. The notion of an increased risk of liv-
er cancer other than angiosarcoma, on the other hand,
is supported by the dose-response analysis performed
in the European study, which suggested a trend in mor-
tality from hepatocellular carcinoma (10 deaths) accord-
ing to estimated cumulative exposure to vinyl chloride
(5). Additional support comes from the results of the
study from Taiwan (13). Out of 25 deaths from liver
cancer, 9 had a pathologically or clinically confirmed
hepatocellular carcinoma, while there were no con-
firmed cases of angiosarcoma of the liver. The carcino-
genic effect of vinyl chloride on hepatocytes may in-
volve a synergism with other causes of hepatocellular
carcinoma, notably infection with hepatitis B virus
(HBV). Out of 16 cases of liver cancer in the study from
Taiwan (13) with known HBV status, 15 were positive
for the virus. Furthermore, in the three studies provid-
ing relevant results (4, 5, 13), the mortality from liver
cancer (excluding angiosarcoma of the liver) was almost
completely offset by a corresponding decrease in mor-
tality from liver cirrhosis, a finding suggesting that vi-
nyl chloride enhances carcinogenesis in an otherwise
chronically damaged liver.
Our results on soft-tissue sarcomas are consistent
with the notion, suggested by earlier case reports (40–
42), that exposure to vinyl chloride may cause angiosa-
rcoma or other sarcomas in organs other than the liver.
The results of the North American multicenter study
tended to support this theory, through the increased
SMR for soft-tissue cancers and the identification of
Figure 3. Standardized mortality ratio (SMR) of brain cancer by dura-
tion of employment.
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four deaths from sarcoma (not angiosarcoma) of specif-
ic organs other than the liver. However, this interpreta-
tion is challenged by the findings of the European mul-
ticenter study, which suggested that the increase in SMR
was due to misclassification on the death certificates of
a few cases involving angiosarcoma of the liver (5).
Because of the rarity of these cancers, the difficulty in
determining valid diagnoses from the cause of death
mentioned on the death certificates, and a diminishing
population of heavily exposed workers, it will be diffi-
cult to clarify this issue.
Despite some statistical heterogeneity, the results on
lung cancer were fairly consistent in not showing an
excess. These results are at odds with earlier data sug-
gesting a positive association. Some of the populations
in which increased mortality from lung cancer or an in-
creased incidence of lung cancer was reported have been
included in either the European multicenter study (17,
19, 23) or the North American one (29, 31). In figure 4,
we have summarized the accumulating evidence on an
association between lung cancer and vinyl chloride ex-
posure by presenting the results of repeated meta-anal-
yses conducted on the data reported up to each year be-
tween 1974 and 2002. Using the SMR available before
1987–1990, as well as the suggestion of a higher risk in
some groups with longer durations of exposure and la-
tency, one would have concluded that vinyl chloride
workers may be at increased risk of lung cancer (2).
Results published subsequently, mainly from the two
multicenter studies (14, 26), did not confirm these find-
ings. It should also be stressed that an increased mor-
tality from lung cancer was reported among workers
employed as packers and baggers in the European study
(5).
The reasons for the decreased lung cancer mortality
in the two largest cohorts are unclear. A probable ex-
planation, however, is reduced tobacco consumption
among vinyl chloride workers in comparison with the
consumption of the general population. Data on the
smoking habits of a small proportion of workers from a
Norwegian cohort, which was eventually included in the
European multicenter study (17), suggest that the prev-
alence of tobacco smoking was slightly higher than in
the national population and, accordingly, the SMR for
lung cancer was increased in that cohort. In older po-
lymerization facilities, where ambient exposures to vi-
nyl chloride were likely to have been much higher and
posed an explosion hazard, smoking would have been
prohibited.
Brain cancer has been an object of interest in sever-
al studies. The results of the pooled analysis showed no
statistically significant increase in mortality from brain
cancer, although, among the cohort members employed
the longest in both multicenter studies, elevated risks
were noted. Because the etiology of brain cancers is
poorly understood, and because exposure histories are
unavailable, it is difficult to assess whether the workers
for whom the excess mortality was noted had been ex-
posed to other industrial risk factors.
The pooled analysis of mortality from malignancies
of the lymphatic and hematopoietic system was limited
by the heterogeneity of the study results. Data from the
two largest studies showed no evidence of an associa-
tion with vinyl chloride exposure. This lack of an asso-
ciation also applied to specific groups of neoplasms
(lymphomas, multiple myeloma, and leukemia). How-
ever, the results from three smaller studies (8, 10, 13)
were positive, with limited information on specific ne-
oplasms within this group. The reasons for the hetero-
geneity of the results are unclear, and reporting bias may
have played a role. Taken together, the available results
did not provide strong support for an association be-
tween vinyl chloride exposure and lymphatic and hemat-
opoietic neoplasms, but a negative conclusion is prema-
ture.
Our combined analysis suffers from several limita-
tions. First, the assessment of exposure to vinyl chlo-
ride was, in most studies, limited to data on employ-
ment in vinyl chloride production, and the duration of
employment was the only quantitative exposure indica-
tor. The variability in the probability and level of expo-
sure among production workers is likely to have atten-
uated any association between vinyl chloride and can-
cer.
Second, SMR values and similar measures of asso-
ciation based on indirect standardization depend on the
age structure of the standard population. They may
therefore not be fully comparable. However, if the dif-
ferent populations have similar age structures (as is like-
ly to be the case for the European and North American
vinyl chloride workers studied), the resulting bias is
likely to be very small. However, the fact that mortality
from all cancers was remarkably close to that expected in
both studies may be an argument in favor of combining
Figure 4. Cumulative meta-analysis of lung cancer—pooled standard-
ized mortality ratios (SMR), with their 95% confidence intervals (95%
CI) [diamonds and bars, respectively] and the number of lung cancer
deaths [stars] by year of publication of subsequent reports.
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the results of at least these two studies. Furthermore, we
adopted a random-effects model for our meta-analysis,
which resulted in less precise combined estimates, to
compensate for the possible effect of the difference in
exposure assessment and standard populations among
the studies, in addition to potential problems with the
comparability of SMR values.
Third, the application of a statistical test for hetero-
geneity favors the combination of imprecise results usu-
ally based on fewer observed outcomes, as it is more
difficult to reject the null hypothesis under these circum-
stances. Conversely, results based on larger numbers are
usually more precise, and the test for heterogeneity is
more likely to generate a small P-value, even if the dif-
ference in point estimates is small. This is an inherent
limitation of the methodology, and it calls for careful
interpretation, with more attention paid to the individu-
al estimates than to the combined results. However, in
the case of liver cancer, the results were heterogeneous,
but, for all but one study, they provided evidence of an
increased risk.
In our opinion, the available evidence on the carci-
nogenicity of vinyl chloride has four characteristics that
make it an interesting case in occupational cancer re-
search. In the first place, the agent is a strong risk fac-
tor for a very rare cancer—angiosarcoma of the liver.
In this case, the excess incidence was so striking that it
was “easily” detected by astute clinicians, and strong
evidence was already available in 1975 on the basis of
case reports (24, 43). The relationship between vinyl
chloride exposure and angiosarcoma of the liver is also
one of the most specific industrial chemical carcinogenic
associations commonly seen, with no other known risk
factors (and therefore no potential confounders).
Second, as with many chemical exposures, the ear-
ly epidemiologic evaluations provided suggestive evi-
dence for additional targets of vinyl chloride carcino-
genicity, namely, lung cancer. However, the early re-
sults were not confirmed by subsequent investigations,
which had greater statistical power and better exposure
information. Credible reviews conducted in the 1980s
concluded, on the basis of the evidence available at that
time, that a causal association was plausible in the case
of lung cancer (1, 2). These examples speak for the need
to confirm reports of small excesses of common can-
cers. In the case of lung cancer among vinyl chloride
workers, the early positive results might have been at-
tributable to either confounding by other occupational
exposures or confounding by extra-occupational expo-
sure (most likely tobacco smoking) or to chance.
The third point deals with the slow emergence of the
evidence that malignancies other than liver angiosarco-
ma may be caused by exposure to vinyl chloride. This
may particularly be the case for hepatocellular carcino-
ma. Small excesses of rare tumors with long latency
periods need therefore to be assessed with long follow-
ups. However, while the meta-analysis supports a small
excess of liver cancers apart from angiosarcoma and oth-
er studies and evidence exists that supports the hypoth-
esis, clearer evidence is still needed. For a large pro-
portion of the liver cancer deaths, it remains unclear
whether they represent under-ascertained angiosarcomas
or not.
Fourth, the recent results on soft-tissue sarcoma of
the two multicenter cohort studies argue for great care
in the interpretion of results on rare tumors that may
suffer from diagnostic misclassification. In the case of
the European multicenter study, an overestimation of the
SMR arose from the misclassification of liver angiosar-
coma as sarcoma from other, or unspecified, organs.
Given the rarity of soft-tissue sarcomas, and the rela-
tively large number of liver angiosarcomas, a misclas-
sification of 10% of the cases of this neoplasm was suf-
ficient to generate a twofold increase in the estimated
mortality from soft-tissue sarcoma. In the North Ameri-
can multicenter study, there was also evidence of mis-
diagnosed angiosarcomas coded as soft-tissue cancers;
however, even after these cases were removed, there
were 8 observed cases, against 4.4 expected, 7 of which
had clear diagnoses other than angiosarcoma of the liver.
Therefore, also in the case of soft-tissue sarcoma,
more evidence is required, and the diagnosis of report-
ed deaths from these neoplasms should be subject to
careful investigation. The present evidence points to-
wards a possible effect of vinyl chloride exposure on
neoplasms other than liver angiosarcoma.
It is unlikely that additional, large cohorts of work-
ers exposed to high levels of this agent will be enrolled
in the future, mainly due to the drastic decrease in ex-
posure levels that took place in the vinyl chloride in-
dustry after 1974, following the publication of convinc-
ing evidence of carcinogenic activity on the liver. Ad-
ditional extension of the follow-up of existing multicent-
er studies may help to elucidate these issues; however,
the maximum latency period for many, if not most, can-
cers is approaching, and additional cancers are more and
more likely to reflect background and other risk factors
other than vinyl chloride.
Large populations of vinyl chloride workers who
experienced different levels of exposure are available
in countries where occupational cohort studies are fea-
sible, notably in Central and Eastern European countries.
Such studies would provide additional information that
would contribute to the elucidation of the main open
questions on vinyl chloride carcinogenicity (effect on
soft-tissue sarcoma, liver cancers other than angiosar-
coma). The available cohort studies should be expand-
ed to include workers employed only after the dramatic
decrease in exposure levels, to investigate the risk of
angiosarcoma at low doses.
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In addition, a very promising approach in cases of
experimental and human angiosarcomas is the identifi-
cation of a mutation in the p53 gene, which is relatively
specific for vinyl chloride exposure (44, 45). There are
sparse data on the analysis of p53 mutation in other tu-
mors of exposed workers; results on hepatocellular car-
cinoma, however, are consistent with a carcinogenic ef-
fect (46). There is need for larger studies of p53 muta-
tion in tumors, other than liver angiosarcoma, that ap-
pear in workers exposed to vinyl chloride.
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